Clinicopathological indices to predict hepatocellular carcinoma molecular classification

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is the second most lethal cancer due to lack of effective therapies. Although promising, HCC molecular classification, which enriches potential responders to specific therapies, has not yet been assessed in clinical trials of anti-HCC drugs. We a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Liver Int
Main Authors: Tan, Poh Seng, Nakagawa, Shigeki, Goossens, Nicolas, Venkatesh, Anu, Huang, Tiangui, Ward, Stephen C., Sun, Xiaochen, Song, Won-Min, Koh, Anna, Canasto-Chibuque, Claudia, Deshmukh, Manjeet, Nair, Venugopalan, Mahajan, Milind, Zhang, Bin, Fiel, Maria Isabel, Kobayashi, Masahiro, Kumada, Hiromitsu, Hoshida, Yujin
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674393/
https://ncbi.nlm.nih.gov/pubmed/26058462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.12889
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki